We are live on ! Find out more
Kintegral Advisory

Kintegral Advisory Portfolio holdings

AUM $1.27B Turnover 3.78%
1-Year Est. Return 34.34%
This Fund
S&P 500
This Quarter Est. Return
+5.15%
1 Year Est. Return
+34.34%
3 Year Est. Return
+143.36%
5 Year Est. Return
+174.21%
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
+$34.9M
Cap. Flow
+$19.5M
Cap. Flow %
1.54%
Top 10 Hldgs %
37.85%
Holding
238
New
4
Increased
229
Reduced
–
Closed
5
Avg Time Held
5.9 years
Top 10 Avg Time Held
3.3 years
Top 20 Avg Time Held
3.1 years

Sector Composition

Rank Sector Weight
1 Technology 40.9%
2 Financials 16.47%
3 Healthcare 14.01%
4 Communication Services 10.19%
5 Consumer Discretionary 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ECL icon
51
Ecolab
ECL
$80.8B
$5.8M 0.46%
21,075
+119
+0.6% +$33K
2018 Q4
31 quarters
TMO icon
52
Thermo Fisher Scientific
TMO
$254B
$5.76M 0.45%
8,521
+48
+0.6% +$28.5K
2022 Q4
15 quarters
EW icon
53
Edwards Lifesciences
EW
$50.9B
$5.51M 0.43%
63,868
+361
+0.6% +$32.1K
2018 Q4
31 quarters
CVS icon
54
CVS Health
CVS
$121B
$5.3M 0.42%
61,828
+349
+0.6% +$34.2K
2018 Q4
31 quarters
TEL icon
55
TE Connectivity
TEL
$61.9B
$5.24M 0.41%
24,810
+140
+0.6% +$29K
2018 Q4
31 quarters
DHR icon
56
Danaher
DHR
$158B
$5.2M 0.41%
23,417
+132
+0.6% +$27.1K
2022 Q4
15 quarters
PFG icon
57
Principal Financial Group
PFG
$23.1B
$5.08M 0.4%
45,389
+256
+0.6% +$29K
2018 Q4
31 quarters
COR icon
58
Cencora
COR
$65.5B
$5.05M 0.4%
16,833
+95
+0.6% +$29.8K
2018 Q4
31 quarters
IBM icon
59
IBM
IBM
$228B
$5.02M 0.4%
22,829
+129
+0.6% +$30.6K
2018 Q4
31 quarters
LIN icon
60
Linde
LIN
$231B
$4.89M 0.39%
10,311
+58
+0.6% +$28.5K
2024 Q2
9 quarters
MET icon
61
MetLife
MET
$64.3B
$4.74M 0.37%
50,383
+284
+0.6% +$27.1K
2018 Q4
31 quarters
CNH icon
62
CNH Industrial
CNH
$18.6B
$4.73M 0.37%
368,479
+2,082
+0.6% +$24.3K
2024 Q2
9 quarters
PFE icon
63
Pfizer
PFE
$172B
$4.61M 0.36%
161,504
+912
+0.6% +$24.3K
2018 Q4
31 quarters
HIG icon
64
Hartford Financial Services
HIG
$36.9B
$4.58M 0.36%
37,210
+210
+0.6% +$28.8K
2018 Q4
31 quarters
AFL icon
65
Aflac
AFL
$60.3B
$4.51M 0.36%
40,354
+228
+0.6% +$27.3K
2018 Q4
31 quarters
CRH icon
66
CRH
CRH
$56.7B
$4.49M 0.35%
54,217
+306
+0.6% +$29.3K
2024 Q2
9 quarters
NOW icon
67
ServiceNow
NOW
$155B
$4.39M 0.35%
32,794
+185
+0.6% +$22.7K
2018 Q4
31 quarters
TWLO icon
68
Twilio
TWLO
$39.7B
$4.36M 0.34%
14,919
+84
+0.6% +$19.1K
2022 Q4
15 quarters
MMM icon
69
3M
MMM
$88.4B
$4.31M 0.34%
26,244
+148
+0.6% +$25.2K
2018 Q4
31 quarters
MDT icon
70
Medtronic
MDT
$121B
$4.29M 0.34%
49,276
+278
+0.6% +$24.5K
2018 Q4
31 quarters
WELL icon
71
Welltower
WELL
$172B
$4.27M 0.34%
18,555
+104
+0.6% +$24.6K
2020 Q2
25 quarters
CMI icon
72
Cummins
CMI
$73.8B
$4.19M 0.33%
8,117
+45
+0.6% +$27.2K
2018 Q4
31 quarters
CBRE icon
73
CBRE Group
CBRE
$38.9B
$4.18M 0.33%
32,515
+183
+0.6% +$26.2K
2018 Q4
31 quarters
CI icon
74
Cigna
CI
$81B
$4.11M 0.32%
15,123
+85
+0.6% +$24K
2018 Q4
31 quarters
CDNS icon
75
Cadence Design Systems
CDNS
$88.1B
$4.1M 0.32%
12,421
+70
+0.6% +$23K
2018 Q4
31 quarters

Similar funds

Kintegral Advisory's Q3 2026 Portfolio in Review

As of Q3 2026, Kintegral Advisory held 238 positions worth $1.27B, up 2.8% from $1.23B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Trading was light in Q3 2026: portfolio turnover was 3.8%. Kintegral Advisory opened 4 new positions and exited 5, leaving the 238-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Financials and Healthcare.

  • Kintegral Advisory's largest Q3 2026 buy was Coca-Cola Consolidated: 172,584 shares worth $14.9M.
  • Kintegral Advisory added most to NVIDIA in Q3 2026, an estimated $700K increase.
  • Kintegral Advisory fully exited Coca-Cola in Q3 2026, selling an estimated $14M.
  • Kintegral Advisory's ten largest holdings make up 38% of its $1.27B portfolio in Q3 2026.
  • Kintegral Advisory opened 4 new positions and closed 5 in Q3 2026.
  • Kintegral Advisory's portfolio value rose 2.8% quarter-over-quarter to $1.27B.

Based on Kintegral Advisory's 13F filing for Q3 2026, filed 16 Oct 2026.